Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

New technology could revolutionize market of 500 million diabetes patients (i24 News). LIVE CHART Oramed Pharmaceuticals (ORMP) developed insulin capsule that can be consumed orally A new...
Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive and board member with more than 25 years of success spanning healthcare, technology, education and retail....
Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied on athletic...
Biotech Stock Review, Dicerna DRNA

Adding Dicerna (DRNA) $3.30 to Watch List.

Adding Dicerna (DRNA) $3.30 to Watch List. How fun would it be to sell a $3.00 idea (IMMU) at $9.00 you got from us and...

Latest article

Biotech Stock Review, Nutriband

Report III: A Deeper Dive Into the Nutriband’s (NTRB) $200 Million Revenue Estimate.

Look at the Basic Math and Decide for Yourself. Click Here to Open News coverage and reporting client. See report for full disclosure and disclaimer details. Standard...

Report II: Updating Coverage on Nutriband (NTRB) $7.77.

Hmm. The number 777 is commonly interpreted as a sign of spiritual alignment, good fortune. Let's hope these revenue forecasts are on the money!...
Pan Global Resources, Institutional Gold Analyst

Pan Global Resources (PGZ) Investor Presentation.

Pan Global Resources (PGZ, PGZFF) a Proven Ground Exploration company, will doing a non-deal roadshow in the Palm Beach Area tonight. We'll attend and...